{"id":16956,"date":"2024-03-21T16:23:51","date_gmt":"2024-03-21T07:23:51","guid":{"rendered":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/?page_id=16956"},"modified":"2026-01-08T16:42:59","modified_gmt":"2026-01-08T07:42:59","slug":"results","status":"publish","type":"page","link":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/department\/center\/diagnostic-pathology-center\/results\/","title":{"rendered":"\u75c5\u7406\u90e8 \u81e8\u5e8a\u7814\u7a76\u767a\u8868\u5b9f\u7e3e"},"content":{"rendered":"\n

\u5e73\u621030\u5e74\u5ea6\uff5e\u4ee4\u548c6\u5e74\u5ea6<\/h2>\n\n\n\n

\u4ee4\u548c6\u5e74\u5ea6<\/h3>\n\n\n\n

\u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

    \n
  1. Goto M\u3001Futamura Y\u3001Makishima H\u3001Saito T\u3001Sakamoto N\u3001Iijima T\u3001Tamaki Y\u3001Okumura T\u3001Sakurai T\u3001Sakurai H.\u00a0 Development of a deep learning-based model to evaluate changes during radiotherapy using cervical cancer digital pathology.\u00a0 Journal of Radiation Resarch 66\uff082\uff09\uff1a144\uff0d156\u3001 2025<\/li>\n<\/ol>\n\n\n\n

    \u3010\u5b66\u4f1a\u767a\u8868\u30fb\u7814\u4fee\u4f1a\u8b1b\u5e2b\u7b49\u3011<\/p>\n\n\n\n

      \n
    1. \u98ef\u5d8b\u9054\u751f.\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u6cbb\u7642\u306e\u7d4c\u904e\u4e2d\u306bE\u578b\u809d\u708e\u611f\u67d3\u304c\u6301\u7d9a\u3057\u305f\u809d\u7d30\u80de\u764c\u306e\u4e00\u4f8b.\u7b2c39\u56de \u770c\u5357\u770c\u897f\u809d\u75be\u60a3\u7814\u7a76\u4f1a\u30012025.2(\u3064\u304f\u3070)\u00a0<\/li>\n\n\n\n
    2. \u5b89\u7530\u4e00\u3001\u6e21\u9089\u4f91\u5948\u3001\u6589\u85e4\u4ec1\u662d\u3001\u6e05\u5d8b\u8b77\u4e4b\u3001\u4e2d\u5ca1\u6d69\u4e8c\u90ce\u3001\u83ca\u6c60\u614e\u4e8c\u3001\u4f0a\u4f50\u9593\u6a39\u751f\u3001\u98ef\u5d8b\u9054\u751f. \u6c17\u7ba1\u652f\u539f\u767aglomus\u816b\u760d\u306e1\u4f8b. \u7b2c56\u56de \u8328\u57ce\u75c5\u9662\u75c5\u7406\u533b\u306e\u4f1a\u30012025.2\uff08\u3064\u304f\u3070\uff09<\/li>\n\n\n\n
    3. \u5c0f\u6797\u5343\u611b\u5948\u3001\u5c0f\u4e95\u6238\u7dbe\u5b50\u3001\u5800\u76f4\u7f8e\u3001\u85e4\u6cbc\u5ec9\u3001\u5b89\u7530\u771f\u5927\u3001\u53e4\u6751\u7950\u7d00\u3001\u963f\u90e8\u9999\u7e54\u3001\u9053\u4e0a\u5927\u96c4\u3001\u8d8a\u667a\u5bdb\u5e78\u3001\u6c96\u660e\u5178\u3001\u6e21\u9089\u4f91\u5948\u3001\u6589\u85e4\u4ec1\u662d\u3001\u98ef\u5d8b\u9054\u751f. \u5185\u819c\u7d30\u80de\u8a3a\u3092\u5951\u6a5f\u306b\u767a\u898b\u3055\u308c\u305f\u907a\u4f1d\u6027\u4e73\u764c\u5375\u5de3\u764c\uff08HBOC\uff09\u306e\u4e00\u4f8b.\u7b2c39\u56de \u8328\u57ce\u770c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a\u30012025.3\uff08\u6c34\u6238\uff09<\/li>\n<\/ol>\n\n\n\n

      \u4ee4\u548c5\u5e74\u5ea6<\/h3>\n\n\n\n

      \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

        \n
      1. \u963f\u90e8\u9999\u7e54\u3001\u5c0f\u4e95\u6238\u7dbe\u5b50\u3001\u98ef\u5d8b\u9054\u751f.\uff1a\u75c5\u7406\u691c\u4f53\u53d6\u308a\u9055\u3048\u6642\u306e\u691c\u4f53\u8b58\u5225\u306e\u624b\u6cd5-\u81e8\u5e8a\u691c\u67fb\u3067\u3067\u304d\u308b\u3053\u3068-\u3001\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5354\u8b70\u4f1a\u96d1\u8a8c\u30012023;62(4):46-50 <\/li>\n<\/ol>\n\n\n\n

        \u4ee4\u548c4\u5e74\u5ea6<\/h3>\n\n\n\n

        \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

          \n
        1. \u963f\u90e8\u9999\u7e54\u3001\u5c0f\u4e95\u6238\u7dbe\u5b50\u3001\u5b89\u7530\u771f\u5927\u3001\u53e4\u6751\u7950\u6a39\u3001\u6e21\u9089\u4f91\u5948\u3001\u6589\u85e4\u4ec1\u662d\u3001\u98ef\u5d8b\u9054\u751f. \u8fc5\u901f\u7d30\u80de\u8a3a(ROSE)\u306e\u6709\u7528\u6027\u3068\u5b9f\u969b.  Medical Technology. 2022;50(10):1094-1103 <\/li>\n<\/ol>\n\n\n\n

          \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

            \n
          1. \u5c0f\u4e95\u6238\u7dbe\u5b50\u3000\u3084\u3063\u3066\u307f\u3066\u308f\u304b\u3063\u305f\uff01\u80ba\u304c\u3093\u907a\u4f1d\u5b50\u691c\u67fb\u3000\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662 Version  \u3084\u3063\u3066\u307f\u3066\u308f\u304b\u3063\u305f\uff01\u80ba\u304c\u3093\u907a\u4f1d\u5b50\u691c\u67fb\u5b9f\u8df5\u304a\u60a9\u307f\u89e3\u6c7a\u30bb\u30df\u30ca\u30fc  2022\u5e748\u670818\u65e5<\/li>\n\n\n\n
          2. \u963f\u90e8\u9999\u7e54\u3000\u907a\u4f1d\u5b50\u30fb\u75c5\u7406\u691c\u67fb\u5ba4ISO15189 \u2013Before & After-  \u30a2\u30fc\u30af\u30ec\u30a4\u907a\u4f1d\u5b50Web Live Sminar2022  2022\u5e748\u670827\u65e5<\/li>\n\n\n\n
          3. \u5b89\u7530\u771f\u5927\u3000\u547c\u5438\u5668\u75c7\u4f8b\u89e3\u8aac\u30002022\u5e74\u5ea6\u7b2c1\u56de\u8328\u57ce\u770c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7814\u4fee\u4f1a\u30002022\u5e749\u67084\u65e5<\/li>\n\n\n\n
          4. \u4e0b\u6597\u7c73\u88d5\u7f8e\u3001\u4ed6\u3000\u8a66\u85ac\u30fb\u6d88\u8017\u54c1\u7ba1\u7406\u30b7\u30b9\u30c6\u30e0\u5316\u306b\u3088\u308b\u52b9\u7387\u5316\u306b\u3064\u3044\u3066\u3000\u7b2c40\u56de\u8328\u57ce\u770c\u81e8\u5e8a\u691c\u67fb\u5b66\u4f1a\u30002022\u5e7411\u67086\u65e5<\/li>\n\n\n\n
          5. \u963f\u90e8\u9999\u7e54\u3000\u75c5\u7406\u691c\u4f53\u53d6\u308a\u9055\u3048\u6642\u306e\u691c\u4f53\u8b58\u5225\u306e\u624b\u6cd5 \u2013\u81e8\u5e8a\u691c\u67fb\u3067\u3067\u304d\u308b\u3053\u3068-\u3000\u7b2c60\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30002022\u5e7411\u670811\u6708<\/li>\n\n\n\n
          6. \u5c0f\u4e95\u6238\u7dbe\u5b50\u3000\u5f53\u9662\u306e\u691c\u67fb\u4f53\u5236\u304cSARS-CoV-2 PCR\u6301\u7d9a\u967d\u6027\u598a\u5a66\u306e\u5468\u7523\u671f\u7ba1\u7406\u30fb\u611f\u67d3\u7ba1\u7406\u306b\u8ca2\u732e\u3057\u305f\u4e00\u4f8b\u3000\u7b2c60\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30002022\u5e7411\u670811\u6708<\/li>\n\n\n\n
          7. \u963f\u90e8\u9999\u7e54\u3000\u75c5\u7406\u533b\u8ca0\u62c5\u8efd\u6e1b\u306e\u305f\u3081\u306e\u75c5\u7406\u62c5\u5f53\u306e\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306b\u3088\u308b\u5207\u308a\u51fa\u3057\u696d\u52d9\u3000\u300c\u75c5\u68df\u696d\u52d9\u3068\u30bf\u30b9\u30af\u30fb\u30b7\u30d5\u30c8\/\u30b7\u30a7\u30a2\u63a8\u9032\u300d\u8b1b\u7fd2\u4f1a\u30002023\u5e742\u670818\u65e5<\/li>\n\n\n\n
          8. \u963f\u90e8\u9999\u7e54\u3000\u7b2c\u56db\u56de\u5916\u90e8\u7cbe\u5ea6\u7ba1\u7406\u8abf\u67fb\u3000\u7d50\u679c\u5831\u544a\u3000\u7b2c9\u56de\u907a\u4f1d\u5b50\u75c5\u7406\u30fb\u691c\u67fb\u8a3a\u65ad\u7814\u7a76\u4f1a \u5b9a\u671f\u5831\u544a\u4f1a  2023\u5e742\u670818\u65e5<\/li>\n\n\n\n
          9. \u963f\u90e8\u9999\u7e54\u3000\u304c\u3093\u30b2\u30ce\u30e0\u5916\u6765\u3078\u30b5\u30dd\u30fc\u30c8\u30e1\u30f3\u30d0\u30fc\u3068\u3057\u3066\u306e\u53c2\u753b\u3000\u591a\u5730\u70b9\u81e8\u5e8a\u691c\u67fb\u30e1\u30c7\u30a3\u30ab\u30eb\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30002023\u5e743\u670817\u65e5<\/li>\n\n\n\n
          10. \u5c0f\u4e95\u6238\u7dbe\u5b50\u3000\u30df\u30b9\u30de\u30c3\u30c1\u4fee\u5fa9\u907a\u4f1d\u5b50\u306b\u95a2\u3059\u308b\u81e8\u5e8a\u691c\u67fb \u2013\u514d\u75ab\u7d44\u7e54\u5316\u5b66\u3068\u30e1\u30c1\u30eb\u5316\u89e3\u6790-\u591a\u5730\u70b9\u81e8\u5e8a\u691c\u67fb\u30e1\u30c7\u30a3\u30ab\u30eb\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30002023\u5e743\u670817\u65e5<\/li>\n<\/ol>\n\n\n\n

            \u4ee4\u548c3\u5e74\u5ea6<\/h3>\n\n\n\n

            \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

              \n
            1. Y.Uchida, J.Imura, K.Abe, et al.\u3000Oxyphilic clear cell carcinoma of ovary:  A distinct cytomorphological finf\\dings.  Diagnostic Cytology  2021;49(9):1063-1066\u3000<\/li>\n\n\n\n
            2. D.Akine, T.Sasahara, A.Koido, et al.  Case of  pregnant woman with probable prolonged SARS-CoV-2 viral shedding 221 days after diagnosis.  Jorunal of Infection and Chemotherapy  2022;28(7):998-1000<\/li>\n<\/ol>\n\n\n\n

              \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

                \n
              1. \u963f\u90e8\u9999\u7e54\u3001\u4ed6\u3000\u547c\u5438\u5668\u9818\u57df\u306b\u304a\u3051\u308b\u6db2\u72b6\u5316\u7d30\u80de\u8a3a\u691c\u4f53\u306e\u6709\u7528\u6027\u3068\u305d\u306e\u5fdc\u7528\u306b\u5411\u3051\u3066  \u7b2c62\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\uff08\u6625\u5b63\u5927\u4f1a\uff09\u30002021\u5e746\u67085\u65e5<\/li>\n\n\n\n
              2. \u963f\u90e8\u9999\u7e54\u3000\u30ef\u30f3\u30dd\u30a4\u30f3\u30c8\u30bb\u30df\u30ca\u30fc\u7b2c2\u5f3e \u5b9f\u969b\u306e\u691c\u67fb\u5ba4\u3000\u907a\u4f1d\u5b50\u75c5\u7406\u30fb\u691c\u67fb\u8a3a\u65ad\u7814\u7a76\u4f1a\u7b2c2\u56de\u30ef\u30f3\u30dd\u30a4\u30f3\u30c8\u30bb\u30df\u30ca\u30fc\u30002022\u5e742\u67088\u65e5<\/li>\n\n\n\n
              3. \u53e4\u6751\u88d5\u7d00\u3000\u7d30\u80de\u691c\u67fb\u5206\u91ce\u306e\u7cbe\u5ea6\u7ba1\u7406\u4e8b\u696d\u5831\u544a\u30002021\u5e74\u5ea6\u7b2c1\u56de\u7d30\u80de\u691c\u67fb\u5206\u91ce\u7814\u4fee\u4f1a\u30002022\u5e742\u670813\u65e5<\/li>\n\n\n\n
              4. \u9234\u6728\u3001\u963f\u90e8\u9999\u7e54\u3001\u5c0f\u4e95\u6238\u7dbe\u5b50\u3001\u4ed6\u3000Interaction of warfarin and lenvatinib in a patient with hepatocellular carcinoma  \u7b2c19\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002022\u5e742\u670818\u65e5<\/li>\n\n\n\n
              5. \u963f\u90e8\u9999\u7e54\u30002021\u5916\u90e8\u7cbe\u5ea6\u7ba1\u7406\u8abf\u67fb\u306e\u7d50\u679c\u5831\u544a\u3000\u7b2c8\u56de\u907a\u4f1d\u5b50\u75c5\u7406\u30fb\u691c\u67fb\u8a3a\u65ad\u7814\u7a76\u4f1a\u5b9a\u671f\u5831\u544a\u4f1a\u30002022\u5e742\u670820\u65e5<\/li>\n<\/ol>\n\n\n\n

                \u4ee4\u548c2\u5e74\u5ea6<\/h3>\n\n\n\n

                \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                  \n
                1. \u5c0f\u4e95\u6238\u7dbe\u5b50\u3001\u4ed6\u3000\u300c\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306b\u3088\u308b\u691c\u67fb\u7d50\u679c\u306e\u7d39\u4ecb\u3000\u5f53\u9662\u306b\u304a\u3051\u308bDNA\u30df\u30b9\u30de\u30c3\u30c1\u4fee\u5fa9\u86cb\u767d\u514d\u75ab\u7d44\u7e54\u5316\u5b66\u67d3\u8272\uff08MMR-IHC\uff09\u306e\u5b9f\u969b\u300d\u3000\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5354\u8b70\u4f1a\u96d1\u8a8c\u30002020\u5e74\u7b2c59\u5dfb\u7b2c4\u53f7 647-652<\/li>\n\n\n\n
                2. \u5c0f\u4e95\u6238\u7dbe\u5b50\u3001\u4ed6\u3000\u300c\u7d30\u80de\u8a3a\u306b\u3066\u63a8\u5b9a\u3057\u5f97\u305f\u5b50\u5bae\u4f53\u90e8\u539f\u767a\u5c0f\u7d30\u80de\u795e\u7d4c\u5185\u5206\u6ccc\u7d30\u80de\u764c\u306e1\u4f8b\u300d\u8328\u57ce\u770c\u7acb\u75c5\u9662\u533b\u5b66\u96d1\u8a8c\u30002020\u5e74 \u7b2c37\u5dfb\u7b2c1\u53f7 31-36<\/li>\n<\/ol>\n\n\n\n

                  \u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n

                    \n
                  1. \u963f\u90e8\u9999\u7e54 \u300cSARS-CoV-2\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0PCR\u691c\u67fb \u904b\u7528\u306e\u5b9f\u969b\u3068\u691c\u67fb\u6cd5\u306e\u9078\u629e\u300d\u7b2c\u4e03\u56de\u907a\u4f1d\u5b50\u75c5\u7406\u30fb\u691c\u67fb\u8a3a\u65ad\u7814\u7a76\u4f1a\u3000\u5b9a\u671f\u5831\u544a\u4f1a<\/li>\n\n\n\n
                  2. \u5c0f\u4e95\u6238\u7dbe\u5b50\u3000\u300c\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u306e\u691c\u67fb\u3063\u3066\u5b9f\u969b\u3069\u3093\u306a\u3053\u3068\u3057\u3066\u3044\u308b\u306e\uff1f\u300d\u7b2c26\u56de\u81e8\u5e8a\u691c\u67fb\u30d5\u30a9\u30fc\u30e9\u30e0<\/li>\n<\/ol>\n\n\n\n

                    \u3010\u53d7\u8cde\u3011<\/p>\n\n\n\n

                      \n
                    1. \u963f\u90e8\u9999\u7e54\u3000\u8328\u57ce\u770c\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u4f1a\u3000\u529f\u52b4\u8005\u8868\u5f70<\/li>\n<\/ol>\n\n\n\n

                      \u4ee4\u548c\u5143\u5e74\u5ea6<\/h3>\n\n\n\n

                      \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                        \n
                      1. Kim Y, Shiba-Ishii A, Ramirez K, Murata M,Sakamoto N, Iijima T, Noguchi M. Carcinogen-induced tumors in SFN-transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma.  Cancer Sci. 110(8) 2431-2441, 2019<\/li>\n<\/ol>\n\n\n\n

                        \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

                          \n
                        1. \u5c0f\u4e95\u6238\u7dbe\u5b50.  \u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306b\u3088\u308b\u691c\u67fb\u7d50\u679c\u8aac\u660e\u306e\u7d39\u4ecb\u3000\u5f53\u9662\u306b\u304a\u3051\u308bDNA\u30df\u30b9\u30de\u30c3\u30c1\u4fee\u5fa9\u86cb\u767d\u514d\u75ab\u7d44\u7e54\u5316\u5b66\u67d3\u8272\uff08MMR-IHC\uff09\u306e\u5b9f\u969b.  \u7b2c58\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012019.10\uff08\u798f\u5cf6\uff09<\/li>\n\n\n\n
                        2. \u963f\u90e8\u9999\u7e54.  \u75c5\u7406\u533b\u8ca0\u62c5\u8efd\u6e1b\u306e\u305f\u3081\u306e\u75c5\u7406\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306b\u3088\u308b\u5207\u308a\u51fa\u3057\u696d\u52d9\u306e\u8a66\u307f\u3000\u7b2c58\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012019.10\uff08\u798f\u5cf6\uff09<\/li>\n\n\n\n
                        3. \u963f\u90e8\u9999\u7e54.  \u5f53\u9662\u306b\u304a\u3051\u308b\u75c5\u7406\u533b\u8ca0\u62c5\u8efd\u6e1b\u306e\u305f\u3081\u306e\u75c5\u7406\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306b\u3088\u308b\u5207\u308a\u51fa\u3057\u696d\u52d9.  \u7b2c39\u56de\u8328\u57ce\u770c\u81e8\u5e8a\u691c\u67fb\u5b66\u4f1a\u30012019.11\uff08\u3064\u304f\u3070\uff09<\/li>\n\n\n\n
                        4. \u53e4\u6751\u7950\u7d00.  \u9577\u671f\u7d4c\u904e\u3092\u8ffd\u3063\u305f\u809d\u56a2\u80de\u306b\u767a\u751f\u3057\u305f\u6d78\u6f64\u6027\u7c98\u6db2\u6027\u56a2\u80de\u817a\u764c\u3068\u8a3a\u65ad\u3055\u308c\u305f1\u4f8b.  \u7b2c58\u56de\u3000\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a\u30012019.11\uff08\u5ca1\u5c71\uff09<\/li>\n<\/ol>\n\n\n\n

                          \u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n

                            \n
                          1. \u963f\u90e8\u9999\u7e54.  \u7d30\u80de\u691c\u67fb\u58eb\u306b\u3088\u308bon site\u3067\u306e\u81e8\u5e8a\u8ca2\u732e\u3000\uff5eROSE\u306e\u5b9f\u969b\u3068\u75c5\u7406\u7d30\u80de\u8a3a\u691c\u4f53\u306eQuality control\u3078\u306e\u8a66\u307f\uff5e  2019\u5e74\u5ea6\u7b2c2\u56de\u8328\u57ce\u770c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7814\u4fee\u4f1a\u30012019.11\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                          2. \u963f\u90e8\u9999\u7e54.  \u7b2c1\u56de\u907a\u4f1d\u5b50\u5916\u90e8\u7cbe\u5ea6\u7ba1\u7406\u8abf\u67fb\u7d50\u679c\u5831\u544a  \u907a\u4f1d\u5b50\u75c5\u7406\u30fb\u691c\u67fb\u8a3a\u65ad\u7814\u7a76\u4f1a\u7b2c6\u56de\u5b9a\u671f\u5831\u544a\u4f1a\u30012020.1\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
                          3. \u5c0f\u4e95\u6238\u7dbe\u5b50.  \u81e8\u5e8a\u691c\u67fb\u306b\u304a\u3051\u308b\u30ea\u30f3\u30c1\u75c7\u5019\u7fa4\u5468\u8fba\u306e\u6700\u8fd1\u306e\u8a71\u984c\u3000\uff08\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306e\u7acb\u5834\u304b\u3089\uff09  2019\u5e74\u5ea6\u3000\u7b2c3\u56de\u8328\u57ce\u770c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7814\u4fee\u4f1a\u30012020.1\uff08\u7b20\u9593\uff09<\/li>\n\n\n\n
                          4. \u963f\u90e8\u9999\u7e54.  \u8cea\u306e\u826f\u3044\u75c5\u7406\u691c\u4f53\u306e\u305f\u3081\u306b\uff5e\u547c\u5438\u5668\u9818\u57df\u306b\u304a\u3051\u308b\u75c5\u7406\u8a3a\u65ad\u6a19\u672c\u304b\u3089\u306e\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb\u691c\u4f53\u307e\u3067\uff5e\u3000\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u306e\u53d6\u308a\u7d44\u307f  Lung Cancer seminar in \u571f\u6d66\u30fb\u963f\u898b\u30012020.2\uff08\u963f\u898b\uff09<\/li>\n<\/ol>\n\n\n\n

                            \u5e73\u621030\u5e74\u5ea6<\/h3>\n\n\n\n

                            \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

                              \n
                            1. \u5b89\u7530\u771f\u5927\u3001\u5185\u7530\u597d\u660e\u3001\u963f\u90e8\u9999\u7e54\u3001\u53e4\u6751\u7950\u7d00\u3001\u5c0f\u4e95\u6238\u7dbe\u5b50\u3001\u98ef\u5d8b\u9054\u751f\u3001\u6589\u85e4\u4ec1\u662d.\uff62\u795e\u7d4c\u5185\u5206\u6ccc\u5206\u5316\u3092\u793a\u3059\u4e73\u764c6\u75c7\u4f8b\u306e\u7d30\u80de\u50cf\u306e\u6bd4\u8f03\u691c\u8a0e\uff63\u7b2c34\u56de\u8328\u57ce\u770c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a.2019.3(\u6c34\u6238)<\/li>\n<\/ol>\n\n\n\n

                              \u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n

                                \n
                              1. \u963f\u90e8\u9999\u7e54. \u300c\u907a\u4f1d\u5b50\u691c\u67fb\u306e\u9662\u5185\u904b\u7528\u72b6\u6cc1\u306e\u7d39\u4ecb\u3068\u30c8\u30d4\u30c3\u30af\u30b9\u300d.\u907a\u4f1d\u5b50\u75c5\u7406\u30fb\u691c\u67fb\u8a3a\u65ad\u7814\u7a76\u4f1a\u3000\u7b2c\u4e09\u56de\u5b9a\u671f\u5831\u544a\u4f1a.2018.7(\u4eac\u90fd)<\/li>\n\n\n\n
                              2. \u5c0f\u4e95\u6238\u7dbe\u5b50. \u300c\u5404\u65bd\u8a2d\u3067\u306eROSE\u306e\u53d6\u308a\u7d44\u307f\u306b\u3064\u3044\u3066\u300d.\u5e73\u621030\u5e74\u5ea6\u8328\u57ce\u770c\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u4f1a\u3000\u5f62\u614b\u691c\u67fb\u90e8\u9580\u3000\u7b2c1\u56de\u75c5\u7406\u7d30\u80de\u691c\u67fb\u5206\u91ce\u5408\u540c\u7814\u4fee\u4f1a.20189.20(\u7b20\u9593)<\/li>\n\n\n\n
                              3.  \u963f\u90e8\u9999\u7e54. \u300c\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u306b\u304a\u3051\u308b\u75c5\u7406\u30fb\u7d30\u80de\u8a3a\u691c\u67fb\u5ba4\u306e\u95a2\u308f\u308a\u300d.\u5e73\u621030\u5e74\u5ea6\u8328\u57ce\u770c\u7d30\u80de\u691c\u67fb\u58eb\u4f1a\u7b2c2\u56de\u7814\u4fee\u4f1a.2019.1(\u3064\u304f\u3070)<\/li>\n<\/ol>\n\n\n\n

                                           <\/p>\n\n\n\n

                                            <\/p>\n","protected":false},"excerpt":{"rendered":"

                                \u5e73\u621030\u5e74\u5ea6\uff5e\u4ee4\u548c6\u5e74\u5ea6 \u4ee4\u548c6\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u3010\u5b66\u4f1a\u767a\u8868\u30fb\u7814\u4fee\u4f1a\u8b1b\u5e2b\u7b49\u3011 \u4ee4\u548c5\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u4ee4\u548c4\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u3010\u5b66\u4f1a\u767a\u8868\u3011 \u4ee4\u548c3\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u3010\u5b66\u4f1a\u767a\u8868\u3011 \u4ee4\u548c2\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u3010\u8b1b\u6f14\u3011 \u3010\u53d7\u8cde\u3011 \u4ee4\u548c\u5143\u5e74 […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":258,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","vk-ltc-link":"","vk-ltc-target":"0"},"class_list":["post-16956","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/comments?post=16956"}],"version-history":[{"count":4,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16956\/revisions"}],"predecessor-version":[{"id":25118,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16956\/revisions\/25118"}],"up":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/258"}],"wp:attachment":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/media?parent=16956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}